# Clinical Cases: Oxidative Phosphorylation

## Case 1: Cyanide Poisoning (Electron Transport Chain Inhibition)

### Clinical Image
![Cyanide Poisoning Treatment](case_01_image.jpg)
*Source: [Wikipedia - Cyanide poisoning](https://en.wikipedia.org/wiki/Cyanide_poisoning) - CC BY-SA 4.0*

### Case Presentation
A 45-year-old firefighter is brought to the emergency department after being rescued from a structure fire involving burning synthetic materials. He was found unresponsive inside the building. On arrival, he is obtunded with GCS 8, has cherry-red skin coloration, and is in respiratory distress. Vital signs show heart rate 130, blood pressure 85/50, respiratory rate 28, and oxygen saturation 98% on high-flow oxygen (paradoxically high despite clinical distress). Arterial blood gas reveals severe metabolic acidosis (pH 7.05, lactate 18 mmol/L) with a narrowed arteriovenous oxygen difference. The elevated venous oxygen saturation indicates that tissues cannot extract oxygen despite adequate delivery, a hallmark of histotoxic hypoxia. Cyanide poisoning from smoke inhalation is suspected. He is immediately treated with hydroxocobalamin (Cyanokit), which binds cyanide to form cyanocobalamin (vitamin B12). His mental status rapidly improves, and lactate normalizes over several hours. The mechanism of toxicity is explained: cyanide binds to the ferric (Fe3+) iron in cytochrome c oxidase (complex IV), blocking electron flow to oxygen and halting oxidative phosphorylation throughout the body.

### Key Learning Points
- Cyanide irreversibly inhibits cytochrome c oxidase (complex IV) by binding to the heme iron, preventing the final transfer of electrons to oxygen and halting ATP production via oxidative phosphorylation
- Tissues cannot utilize oxygen even though it is abundant, creating histotoxic hypoxia characterized by elevated venous oxygen saturation and severe lactic acidosis
- Hydroxocobalamin is the preferred antidote as it directly binds cyanide; alternatively, nitrites can be used to generate methemoglobin (which binds cyanide), followed by thiosulfate to convert cyanide to thiocyanate for renal excretion

---

## Case 2: MELAS Syndrome (Mitochondrial DNA Mutation)

### Clinical Image
![MELAS MRI](case_02_image.jpg)
*Source: [Radiopaedia - MELAS syndrome](https://radiopaedia.org/articles/melas) - CC BY-NC-SA 3.0*

### Case Presentation
A 19-year-old woman presents with sudden onset of right-sided weakness and visual disturbance. She has a history of recurrent migraine-like headaches, hearing loss, and exercise intolerance since childhood. Her mother and maternal aunt both have diabetes and hearing loss. Physical examination reveals right hemiparesis and right homonymous hemianopia. Initial CT head is negative for hemorrhage. MRI shows cortical and subcortical T2 hyperintensities in the left parieto-occipital region that do not conform to a single vascular territory. Laboratory studies reveal elevated serum lactate (4.8 mmol/L) and elevated lactate in CSF. Given the stroke-like presentation in a young patient with maternal family history and multisystem involvement, MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes) is suspected. Genetic testing confirms the m.3243A>G mutation in the MT-TL1 gene encoding mitochondrial tRNA-leucine. She is treated supportively with L-arginine (a nitric oxide precursor that may improve cerebral blood flow) and coenzyme Q10 supplementation. The family is counseled about maternal inheritance.

### Key Learning Points
- MELAS is caused by mutations in mitochondrial DNA, most commonly m.3243A>G in the tRNA-leucine gene, which impairs mitochondrial protein synthesis and electron transport chain function
- Mitochondrial diseases follow maternal inheritance because mitochondria are transmitted exclusively through the oocyte; variable heteroplasmy (proportion of mutant vs. normal mtDNA) explains the phenotypic variability
- Tissues with high energy demands (brain, muscle, heart, retina) are most affected; chronic lactic acidosis results from impaired oxidative phosphorylation shunting pyruvate to lactate

---

## Case 3: Brown Fat Thermogenesis in Newborn (Physiological Uncoupling)

### Clinical Image
![Brown Fat PET](case_03_image.jpg)
*Source: [Wikipedia - Brown adipose tissue](https://en.wikipedia.org/wiki/Brown_adipose_tissue) - CC BY-SA 3.0*

### Case Presentation
A premature infant (32 weeks gestational age) is delivered and immediately placed under a radiant warmer. The neonatologist explains to the parents why temperature regulation is critical in preterm infants. Unlike adults who primarily rely on shivering thermogenesis, newborns have limited ability to shiver and instead depend on non-shivering thermogenesis through brown adipose tissue (BAT). Brown fat, located around the neck, interscapular region, and great vessels, contains abundant mitochondria with high levels of uncoupling protein 1 (UCP1/thermogenin). When activated by norepinephrine release in response to cold, UCP1 creates a proton leak across the inner mitochondrial membrane, bypassing ATP synthase. The energy from the proton gradient is dissipated as heat rather than used for ATP synthesis. The infant is kept in a neutral thermal environment to minimize metabolic demand. By 6 months of age, most brown fat will be replaced by white adipose tissue. Recent research has shown that adults retain some metabolically active brown fat, generating interest in activating BAT to combat obesity.

### Key Learning Points
- Uncoupling proteins (UCPs) allow protons to leak across the inner mitochondrial membrane without passing through ATP synthase, dissipating the proton gradient as heat instead of ATP
- Brown adipose tissue is specialized for non-shivering thermogenesis; it appears brown due to high mitochondrial content and is essential for temperature regulation in newborns
- This represents physiological uncoupling in contrast to pathological uncoupling (e.g., 2,4-dinitrophenol poisoning), demonstrating how the same biochemical mechanism can serve beneficial or harmful purposes